TNFSF10 and glioblastoma: TRAIL-producing hi-NSCs induced cell death selectively in GBM cells via caspase-mediated apoptosis, successfully mitigating GBM development and extended median survival in human GBM xenografts (Fig. 3A) [212, 219–221].